Comparison of Two Types of Pain Relief After Cesarean Delivery
NCT ID: NCT01151943
Last Updated: 2016-11-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE4
77 participants
INTERVENTIONAL
2010-10-31
2012-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Transversus Abdominis Plane (TAP) Block
Patients will receive a bilateral transversus abdominis plane block
Transversus Abdominis Plane (TAP) Block
Bilateral injection of levobupivacaine (20 mL, 3.75 mg/mL)
Incisional Infiltration of Local Anesthetic
Patients will receive an incisional infiltration with local anesthetic (continuous administration of levobupivacaïne during 48 hours)
Incisional Infiltration of Local Anesthetic
continuous administration of levobupivacaine (1,25 mg/mL,5 mL/h) during 48 hours.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transversus Abdominis Plane (TAP) Block
Bilateral injection of levobupivacaine (20 mL, 3.75 mg/mL)
Incisional Infiltration of Local Anesthetic
continuous administration of levobupivacaine (1,25 mg/mL,5 mL/h) during 48 hours.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA I or II
* height above 1,55 m
* singleton pregnancy
Exclusion Criteria
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hopital Foch
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marc Fischler, MD
Role: STUDY_CHAIR
Hôpital Foch
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Foch
Suresnes, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Chandon M, Bonnet A, Burg Y, Barnichon C, DesMesnards-Smaja V, Sitbon B, Foiret C, Dreyfus JF, Rahmani J, Laloe PA, Fischler M, Le Guen M. Ultrasound-guided Transversus Abdominis plane block versus continuous wound infusion for post-caesarean analgesia: a randomized trial. PLoS One. 2014 Aug 5;9(8):e103971. doi: 10.1371/journal.pone.0103971. eCollection 2014.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2010-019662-88
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
2010/15
Identifier Type: -
Identifier Source: org_study_id